These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37055331)

  • 21. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
    North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
    Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic diagnosis of adenoid cystic carcinoma of salivary glands.
    Nagel H; Hotze HJ; Laskawi R; Chilla R; Droese M
    Diagn Cytopathol; 1999 Jun; 20(6):358-66. PubMed ID: 10352908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
    Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
    Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
    Bishop JA; Yonescu R; Epstein JI; Westra WH
    Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma.
    Baba S; Akashi T; Kayamori K; Ohuchi T; Ogawa I; Kubota N; Nakano K; Nagatsuka H; Hasegawa H; Matsuzaka K; Tomii S; Uchida K; Katsuta N; Sekiya T; Ando N; Miura K; Ishibashi H; Ariizumi Y; Asakage T; Michi Y; Harada H; Sakamoto K; Eishi Y; Okubo K; Ikeda T
    Pathol Int; 2021 Feb; 71(2):113-123. PubMed ID: 33333616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens.
    Pusztaszeri MP; Sadow PM; Ushiku A; Bordignon P; McKee TA; Faquin WC
    Cancer Cytopathol; 2014 Apr; 122(4):257-65. PubMed ID: 24302647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYB Translocations in Both Myoepithelial and Ductoglandular Epithelial Cells in Adenoid Cystic Carcinoma: A Histopathologic and Genetic Reappraisal in Six Primary Cutaneous Cases.
    Goto K; Kajimoto K; Sugino T; Nakatsuka SI; Yoshida M; Noto M; Kono M; Takai T
    Am J Dermatopathol; 2021 Apr; 43(4):278-283. PubMed ID: 32732690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
    Andreasen S; Melchior LC; Kiss K; Bishop JA; Høgdall E; Grauslund M; Wessel I; Homøe P; Agander TK
    Cancer Cytopathol; 2018 Apr; 126(4):275-281. PubMed ID: 29266837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.
    Thierauf J; Ramamurthy N; Jo VY; Robinson H; Frazier RP; Gonzalez J; Pacula M; Dominguez Meneses E; Nose V; Nardi V; Dias-Santagata D; Le LP; Lin DT; Faquin WC; Wirth LJ; Hess J; Iafrate AJ; Lennerz JK
    Oncologist; 2019 Oct; 24(10):1356-1367. PubMed ID: 30926674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenoid Cystic Carcinoma With Striking Tubular Hypereosinophilia: A Unique Pattern Associated With Nonparotid Location and Both Canonical and Novel EWSR1::MYB and FUS::MYB Fusions.
    Weinreb I; Rooper LM; Dickson BC; Hahn E; Perez-Ordonez B; Smith SM; Lewis JS; Skalova A; Baněčková M; Wakely PE; Thompson LDR; Rupp NJ; Freiberger SN; Koduru P; Gagan J; Bishop JA
    Am J Surg Pathol; 2023 Apr; 47(4):497-503. PubMed ID: 36920022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of xenograft model systems for adenoid cystic carcinoma.
    Moskaluk CA; Baras AS; Mancuso SA; Fan H; Davidson RJ; Dirks DC; Golden WL; Frierson HF
    Lab Invest; 2011 Oct; 91(10):1480-90. PubMed ID: 21709671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of Adenoid Cystic Carcinoma with Striking Tubular Hypereosinophilia by MYB and EWSR1 Breakapart Fluorescence In Situ Hybridization.
    Yadav U; Mahendru R; Sharma J; Kakkar A
    Head Neck Pathol; 2023 Dec; 17(4):940-951. PubMed ID: 38010473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of MYB in salivary gland basal cell adenocarcinoma and basal cell adenoma.
    Rooney SL; Robinson RA
    J Oral Pathol Med; 2017 Oct; 46(9):798-802. PubMed ID: 28727172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma.
    Shao C; Bai W; Junn JC; Uemura M; Hennessey PT; Zaboli D; Sidransky D; Califano JA; Ha PK
    Oral Oncol; 2011 Apr; 47(4):251-5. PubMed ID: 21324728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
    Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
    J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
    Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
    Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
    Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
    Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.